Expression of Nitric Oxide Synthase Isoforms in the Human Placenta Is Not Altered by Labor

Endocrine Journal

Volumn 50, Issue 5, 2003, Pages 535-544

  Kakui, Kazuyo ^a   Sagawa, Norimasa ^a   Itoh, Hiroaki ^a   Yura, Shigeo ^a   Korita, Daizo ^a   Takemura, Maki ^a   Nuamah, Mercy A ^a   Fujii, Shingo ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Guanosine 3 ,5 cyclic monophosphate (cGMP); Nitric oxide synthase; Parturition; Pregnancy; Trophoblast cells

Indexed keywords

CYCLIC AMP; ISOPROTEIN; NITRIC OXIDE SYNTHASE;

AMNION; ARTICLE; CHORION; CLINICAL ARTICLE; CONTROLLED STUDY; DECIDUA; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; LABOR; MYOMETRIUM; PLACENTA; PROTEIN EXPRESSION; TISSUE DISTRIBUTION;

CYCLIC GMP; FEMALE; HUMANS; LABOR, OBSTETRIC; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; OSMOLAR CONCENTRATION; PLACENTA; PREGNANCY; RNA, MESSENGER; UTERUS;

EID: 0344010172     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.50.535     Document Type: Article

References (54)

1. Knowles RG, Moncada S (1994) Nitric oxide synthases in mammals. Biochem J 298: 249-258.
2. Magness RR, Shaw CE, Phernetton TM, Zheng J, Bird IM (1997) Endothelial vasodilator production by uterine and systemic arteries. II. Pregnancy effects on NO synthase expression. Am J Physiol 272: H1730-H1740.
3. Sladek SM, Magness RR, Conrad KP (1997) Nitric oxide and pregnancy. Am J Physiol 272: R441-R463.
4. Parturition (2001) In: Cunningham FG, Gant NF, Leveno KJ, Gilstrap III LC, Hauth, JC, Wenstrom KD (eds) Williams Obstetrics. 21st ed., McGraw-Hill, New York, 261-317.
5. Norman JE, Cameron IT (1996) Nitric oxide in the human uterus. Rev Reprod 1: 61-68.
6. Buhimschi I, Yallampalli C, Dong YL, Garfield RE (1995) Involvement of a nitric oxide-cyclic guanosine monophosphate pathway in control of human uterine contractility during pregnancy. Am J Obstet Gynecol 172: 1577-1584.
7. Garbers DL, Koesling D, Schultz G (1994) Guanylyl cyclase receptors. Mol Biol Cell 5: 1-5.
8. Itoh H, Bird IM, Nakao K, Magness RR (1998) Pregnancy increases soluble and particulate guanylate cyclases and decreases the clearance receptor of natriuretic peptides in ovine uterine, but not systemic, arteries. Endocrinology 139: 3329-3341.
9. Telfer JF, Itoh H, Thomson AJ, Norman JE, Nakao K, Campa JS, Poston L, Tribe RM, Magness RR (2001) Activity and expression of soluble and particulate guanylate cyclases in myometrium from nonpregnant and pregnant women: down-regulation of soluble guanylate cyclase at term. J Clin Endocrinol Metab 86: 5934-5943.
10. Palmer RMJ, Moncada S (1989) A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem Biophys Res Commun 158: 348-352.
11. Lowenstein CJ, Dinnerman JL, Snyder H (1994) Nitric oxide: a physiologic messenger. Ann Intern Med 120: 227-237.
12. Forstermann U, Schmidt HH, Pollock JS, Sheng H, Mitchell JA, Warner TD, Nakane M, Murad F (1991) Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem Pharmacol 42: 1849-1857.
13. Buttery LD, McCarthy A, Springall DR, Sullivan MH, Elder MG, Michel T, Polak JM (1994) Endothelial nitric oxide synthase in the human placenta: regional distribution and proposed regulatory role at the feto maternal interface. Placenta 15: 257-265.
14. Myatt L, Brockman DE, Eis AL, Pollock JS (1993) Immunohistochemical localization of nitric oxide synthase in the human placenta. Placenta 14: 487-495.
15. Conrad KP, Vill M, McGuire PG, Dail WG, Davis AK (1993) Expression of NOS by syncytiotrophoblast in human placental villi. FASEB J 7: 1269-1276.
16. Myatt L, Eis AL, Brockman DE, Greer IA, Lyall F (1997) Endothelial nitric oxide synthase in placental villous tissue from normal, preeclamptic and intrauterine growth restricted pregnancies. Hum Reprod 12: 167-172.
17. Myatt L, Brockman DE, Langdon G, Pollock JS (1993) Constitutive calcium dependent isoform of nitric oxide synthase in the human placental villous vascular tree. Placenta 14: 373-383.
18. Myatt L, Eis AL, Brockman DE, Kossenjans W, Greer I, Lyall F (1997) Inducible (type II) nitric oxide synthase in human placental villous tissue of normotensive, preeclamptic and intrauterine growth-restricted pregnancies. Placenta 18: 261-268.
19. Morris NH, Sooranna SR, Learmont JG, Poston I, Ramsey B, Pearson JD, Steer PJ (1995) Nitric oxide synthase activities in placental tissue from normotensive, preeclamptic and growth retarded pregnancies. Br J Obstet Gynaecol 102: 711-714.
20. Garvey EP, Tuttle JV, Covington K, Merril BM, Wood ER, Baylis SA, Charles IG (1994) Purification and characterization of the constitutive nitric oxide synthase from human placenta. Arch Biochem Biophys 311: 235-241.
21. Schonfelder G, John M, Hopp H, Fuhr N, van Der Giet M, Paul M (1996) Expression of inducible nitric oxide synthase in placenta of women with gestational diabetes. FASEB J 10: 777-784
22. Conrad KP, Davis AK (1995) Nitric oxide synthase activity in placentae from women with preeclampsia. Placenta 16: 691-699.
23. Ghabour MS, Eis AL, Brockman DE, Pollock JS, Myatt L (1995) Immunohistochemical characterization of placental nitric oxide synthase expression in preeclampsia. Am J Obstet Gynecol 173: 687-694.
24. Lyall F, Jablonka-Shariff A, Johnson RD, Olson LM, Nelson DM (1998) Gene expression of nitric oxide synthase in cultured human term placental trophoblast during in vitro differentiation. Placenta 19: 253-260.
25. Napolitano M, Miceli F, Calce A, Vacca A, Gulino A, Apa R, Lanzone A (2000) Expression and relationship between endothelin-1 messenger ribonucleic acid (mRNA) and inducible/endothelial nitric oxide synthase mRNA isoforms from normal and preeclamptic placentas. J Clin Endocrinol Metab 85: 2318-2323.
26. Nanno H, Sagawa N, Itoh H, Matsumoto T, Terakawa K, Mori T, Itoh H, Nakao K (1998) Nitric oxide metabolite concentrations in maternal plasma decrease during parturition: possible transient down-regulation of nitric oxide synthesis. Mol Hum Reprod 4: 609-616.
27. Masuzaki H, Ogawa Y, Sagawa N, Hosoda K, Matsumoto T, Mise H, Nishimura H, Yoshimasa Y, Tanaka I, Mori T, Nakao K (1997) Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med 3: 1029-1033.
28. Heid, CA, Stevens J, Livak KJ, Williams PM (1996) Real time quantitative PCR. Genom Res 6: 986-994.
29. Yoshida M, Sagawa N, Itoh H, Yura S, Korita D, Kakui K, Hirota N, Sato T, Ito A, Fujii S (2001) Nitric oxide increases matrix metalloproteinase-1 production in human uterine cervical fibroblast cells. Mol Hum Reprod 7: 979-985.
30. Nadaud S, Bonnardeaux A, Lathrop M, Soubrier F (1994) Gene structure, polymorphism and mapping of the human endothelial nitric oxide synthase gene. Biochem Biophys Res Commun 198: 1027-1033.
31. Chartrain NA, Geller DA, Koty PP, Sitrin NF, Nussler AK, Hoffman EP, Billiar TR, Hutchinson NI, Mudgett JS (1994) Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J Biol Chem 269: 6765-6772.
32. Tso JY, Sun XH, Kao TH, Reece KS, Wu R (1985) Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. Nucleic Acid Res 13: 2485-2502.
33. Myatt L, Brewer AS, Langdon G, Brockman DE (1992) Attenuation of the vasoconstrictor effects of tromboxane and endothelin by nitric oxide in the human fetal placental circulation. Am J Obstet Gynecol 166: 224-230.
34. Myatt L, Brewer AS, Brockman DE (1991) The action of nitric oxide in the perfused human fetal-placental circulation. Am J Obstet Gynecol 164: 687-692.
35. Ramsay B, De Belder A, Campbell S, Moncada S, Martin JF (1994) A nitric oxide donor improves uterine artery diastolic blood flow in normal early pregnancy and in women at high risk of preeclampsia. Eur J Clin Invest 24: 76-78.
36. Giles W, O'Callaghan S, Boura A, Walters W (1992) Reduction in human fetal umbilical-placental vascular resistance by glyceryl trinitrate. Lancet 340: 856.
37. Janbu T, Nesheim BI (1987) Uterine artery blood velocities during contractions in pregnancy and labour related to intrauterine pressure. Br J Obstet Gynaecol 94: 1150-1155.
38. Janbu T, Koss KS, Nesheim BI, Wesche J (1985) Blood velocities in the uterine artery in humans during labour. Acta Physiol Scand 124: 153-161.
39. Fisher AB, Chien S, Barakat AI, Nerem RM (2001) Endothelial cellular response to altered shear stress. Am J Physiol Lung Cell Mol Physiol 281: L529-L533.
40. Lavallee M, Takamura M, Parent R, Thorin E (2001) Crosstalk between endothelin and nitric oxide in the control of vascular tone. Heart Fail Rev 6: 265-276.
41. Bolli R (2001) Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol 33: 1897-1918.
42. Corbucci GG, Lettieri B, Damonti V, Palombari R, Arienti G, Palmerini CA (2002) Nitric oxide in ischemic and reperfused human muscle. Clin Chim Acta 318: 79-82.
43. Chatterjee PK, Patel NS, Kvale EO, Cuzzocrea S, Brown PA, Stewart KN, Mota-Filipe H, Thiemermann C (2002) Inhibition of inducible nitric oxide synthase reduces renal ischemia/reperfusion injury. Kidney Int 61: 862-871.
44. Gude NM, King RG, Brennecke SP (1998) Autacoid interactions in the regulation of blood flow in the human placenta. Clin Exp Pharmacol Physiol 25: 706-711.
45. Boura AL, Walters WA, Read MA, Leitch IM (1994) Autacoids and control of human placental blood flow. Clin Exp Pharmacol Physiol 21: 737-748.
46. Saxena D, Purohit SB, Kumer GP, Laloraya M (2000) Increased appearance of inducible nitric oxide synthase in the uterus and embryo at implantation. Nitric Oxide 4: 384-391.
47. Fuhrmann U, Hess-Stumpp H, Cleve A, Neef G, Schwede W, Hoffmann J, Fritzemeier KH, Chwalisz K (2000) Synthesis and biological activity of a novel, highly potent progesterone receptor antagonist. J Med Chem 43: 5010-5016.
48. Ariel I, Hochberg A, Shochina M (1998) Endothelial nitric oxide synthase immunoreactivity in early gestation and in trophoblastic disease. J Clin Pathol 51: 427-31.
49. Khorram O (2002) Nitric oxide and its role in blastocyst implantation. Rev Endocr Metab Disord 3: 145-149.
50. Sheppard BL, Bonnar J (1999) Uteroplacental hemostasis in intrauterine fetal growth retardation. Semin Thromb Hemost 25: 443-446.
51. Uszynski M (1991) Tissue anticoagulants in the human placenta: preliminary study with a heparin-like anti-coagulant and review of the literature. Gynecol Obstet Invest 32: 129-133.
52. Bleker OP, Kloosterman GJ, Mieras DJ, Oosting J, Salle HJ (1975) Intervillous space during uterine contractions in human subjects: an ultrasonic study. Am J Obstet Gynecol 123: 697-699.
53. Marton IS, Barakonyi E (1987) Contraction stress testing for primary foetal surveillance by stimulated endogenous oxytocin release. Acta Chir Hung 28: 9-13.
54. van Hinsbergh VW (2001) The endothelium: vascular control of haemostasis. Eur J Obstet Gynecol Reprod Biol 95: 198-201.